Diabetes with Chronic Kidney Disease

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The Hemoglobin A1c (HbA1c) Test measures average blood glucose over 2–3 months by detecting sugar attached to hemoglobin in red blood cells. It is used to diagnose diabetes, identify prediabetes, and monitor long-term blood sugar control. Doctors rely on the HbA1c test to evaluate treatment effectiveness, guide adjustments, and assess risk for complications, making it essential for diabetes care and metabolic health screening.

The Insulin Test measures insulin levels in blood to assess how the body regulates glucose and metabolism. It helps diagnose insulin resistance, hypoglycemia, type 2 diabetes, and metabolic syndrome. Doctors also use it to evaluate pancreatic function and monitor treatment effectiveness. Frequently ordered with glucose testing, the insulin test provides critical insight into endocrine health, blood sugar control, and risk for diabetes-related complications.

The Lipid Panel with Ratios Test measures seven key markers: total cholesterol, HDL, LDL, non-HDL cholesterol, triglycerides, Chol/HDL ratio, and LDL/HDL ratio. This advanced panel evaluates cardiovascular risk by assessing cholesterol balance and fat metabolism. Doctors use it to detect high cholesterol, atherosclerosis risk, and heart disease, and to monitor treatment. Often part of routine exams, it provides insight into long-term heart and metabolic health.

The Apolipoprotein A1 and B Test measures Apo A1, the main protein in HDL cholesterol, and Apo B, the primary protein in LDL and VLDL cholesterol. Together, these markers and the ApoB/A1 ratio provide a clearer picture of cardiovascular risk than standard lipid panels. High ApoB or low Apo A1 may signal heart disease, stroke, or atherosclerosis. Doctors use this test to evaluate cholesterol balance, monitor therapy, and guide prevention of cardiovascular conditions.

The C-Reactive Protein (CRP) Test measures CRP levels in blood to detect inflammation in the body. Elevated CRP may indicate infections, autoimmune disorders, or chronic diseases such as arthritis, cardiovascular disease, or inflammatory bowel disease. Doctors use this test to assess acute illness, monitor treatment response, and evaluate risk for heart disease. The CRP test provides key insight into inflammation, immune health, and overall wellness.

The Carbon Dioxide Test measures CO2 levels in the blood to help assess acid-base balance and metabolic function. Abnormal results may reflect respiratory issues, kidney disorders, or metabolic imbalances such as acidosis or alkalosis. This test is often included in electrolyte panels to provide insights into overall health, fluid balance, and how the body maintains proper pH regulation through the respiratory and renal systems.

The Cardio IQ™ Diabetes and ASCVD Risk Panel with Scores measures advanced cardiovascular and metabolic markers to evaluate risk for atherosclerotic cardiovascular disease and type 2 diabetes. This panel includes lipid analysis, glucose-related biomarkers, and inflammation indicators, helping assess cardiometabolic health. Results provide clinicians with detailed scoring to identify patterns that may influence prevention and long-term disease management.

The Cardio IQ™ Diabetes Risk Panel with Score combines advanced biomarker analysis to evaluate insulin resistance, lipid metabolism, and glycemic control. This panel generates a diabetes risk score that helps identify individuals at increased risk for type 2 diabetes and related cardiometabolic complications. It provides insight into metabolic health, supporting early intervention, lifestyle planning, and long-term disease management.

The Catecholamines Fractionated Plasma Test measures plasma levels of dopamine, epinephrine, and norepinephrine, hormones that regulate stress response, blood pressure, and heart rate. Elevated levels may indicate pheochromocytoma, paraganglioma, or other adrenal and nervous system disorders. Doctors use this test to investigate symptoms like hypertension, headaches, sweating, or palpitations, and to monitor treatment of adrenal tumors.

The Creatinine Test measures creatinine levels in blood to evaluate kidney function and filtration efficiency. Elevated levels may indicate kidney disease, dehydration, or muscle disorders, while low levels may reflect reduced muscle mass. Doctors use this test to monitor chronic kidney disease (CKD), assess treatment response, and detect early signs of renal impairment. It provides key insight into kidney health, metabolic balance, and overall renal function.

The Cystatin C Test with eGFR measures blood levels of Cystatin C, a protein filtered by the kidneys, and calculates estimated glomerular filtration rate (eGFR). This test provides a sensitive marker for kidney function and can detect early kidney disease, even when creatinine levels are normal. Doctors order it to evaluate chronic kidney disease risk, monitor treatment, and assess overall kidney health in patients with diabetes, hypertension, or other conditions.

The Diabetes Risk Panel with Score combines multiple biomarkers to assess risk of developing type 2 diabetes and related metabolic conditions. By evaluating glucose control, insulin resistance, lipid levels, and inflammation markers, this panel provides a personalized score that reflects overall metabolic health. Clinicians use it to help identify individuals at increased risk, support early intervention, and monitor long-term health.

The Ferritin Test measures ferritin, a protein that stores iron in the body, to evaluate iron levels and detect deficiency or overload. It helps diagnose anemia, iron deficiency, hemochromatosis, and chronic disease-related inflammation. Doctors often order the ferritin test to investigate fatigue, weakness, or unexplained symptoms. It is also used to monitor iron supplementation, treatment effectiveness, and overall iron metabolism health.

The Glucagon Test evaluates hormone levels that regulate glucose by stimulating the liver to release stored sugar. Elevated or low glucagon may indicate diabetes, hypoglycemia, metabolic disorders, or pancreatic disease. This test provides insight into endocrine activity, glucose balance, and systemic health conditions related to energy metabolism and hormonal function.

The Hemoglobin Test measures the amount of hemoglobin in blood, the protein that carries oxygen to tissues. Low hemoglobin may indicate anemia, blood loss, or nutritional deficiencies, while high levels may suggest dehydration, lung disease, or bone marrow disorders. Doctors order this test to evaluate fatigue, weakness, or shortness of breath. Results provide key insight into oxygen transport, red blood cell health, and overall hematologic function.

The Lyme Disease Antibody Test with Reflex to Blot IgG IgM screens for antibodies to Borrelia burgdorferi, the bacteria that cause Lyme disease. If results are positive or equivocal, a Western blot IgG/IgM is reflexively performed for confirmation. Doctors order this test for patients with tick exposure, rash, joint pain, or neurological symptoms. Results help confirm infection, guide treatment decisions, and support early detection to prevent complications.

The Albumin 24 Hour Urine with Creatinine Test measures albumin and creatinine excretion over 24 hours to evaluate kidney function. Elevated albumin (albuminuria) may signal early kidney disease, diabetes-related damage, or hypertension. By comparing albumin to creatinine, this test accounts for urine concentration and improves accuracy. Doctors use it to detect kidney injury, monitor chronic disease, and guide treatment or prevention strategies.

The Albumin 24 Hour Urine Test evaluates the amount of albumin released in urine during a full day, serving as an indicator of kidney health. High albumin levels can signal early kidney damage from diabetes, hypertension, or chronic kidney disease. Collecting urine over 24 hours improves accuracy by reflecting daily fluctuations, offering important insight for detecting renal impairment, monitoring progression, and supporting long-term care.